Quantcast
Last updated on April 16, 2014 at 13:05 EDT

Latest Cancer Research Stories

2013-09-30 08:29:32

ALBANY, N.Y., Sept. 30, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that its wholly owned subsidiary, Albany Molecular Research (UK) Ltd., located in Holywell, Wales, United Kingdom, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation. The contract was awarded by the Defense Science and Technology Laboratory (Dstl), acting on behalf of the United Kingdom's Secretary of State for Defence, the...

2013-09-28 23:04:02

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a repurposed FDA-approved drug, discovered by Johns Hopkins researchers, that has halted the growth of adult human brain tumor cells implanted in mice. New York, NY (PRWEB) September 28, 2013 Voices Against Brain Cancer discusses the finding of a repurposed FDA-approved drug that has halted the growth of adult human brain tumor cells in a study conducted by Johns Hopkins researchers....

2013-09-27 23:22:46

Professional cyclist Robbie Ventura to lead inaugural bike ride to benefit cancer clinical trials at Gateway for Cancer Research. Schaumburg, Ill. (PRWEB) September 27, 2013 Ready to make a difference in the fight against cancer, nearly 500 cyclists have signed up to ride the inaugural Trails 4 Trials cycling event on Saturday, Sept. 28, in Goodyear, Arizona. Trials 4 Trials is the first organized charity ride in Arizona’s Southwest Valley, benefiting new cancer clinical trials funded...

2013-09-27 10:17:00

Findings may open up new treatment options by extending therapies effective in one cancer type to others with a similar genomic profile Cancer encompasses a complex group of diseases traditionally defined by where in the body it originates, as in lung cancer or colon cancer. This framework for studying and treating cancer has made sense for generations, but molecular analysis now shows that cancers of different organs have many shared features, while cancers from the same organ or tissue...

2013-09-26 13:01:57

Three grants totaling more than $25 million over four years will help three research groups to develop authoritative information on the millions of genomic variants relevant to human disease and the hundreds that are expected to be useful for clinical practice. The awards are from the National Institutes of Health. More and more medical and research centers are sequencing the DNA of whole genomes (the body's entire genetic blueprint) or exomes (the genome's protein-coding region) of...

2013-09-25 20:22:26

RENO, Nev. and TAHOE, Nev., Sept. 25, 2013 /PRNewswire/ -- Progress and next steps to develop lower-cost proton cancer therapy was the topic of discussion at an international initiative meeting on Friday, September 20th, 2013. Moataz Karmalawy, Ph.D., Vice President and General Manager Worldwide Particle Therapy for Varian Medical Systems (http://www.varian.com/us/oncology/treatments/treatment_techniques/proton_therapy/) shared that proton therapy, in addition to its current...

2013-09-24 23:34:41

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a specific protein being found in nearly 100 percent of high-grade meningiomas, suggesting a new target for cancer therapies. New York, NY (PRWEB) September 24, 2013 Voices Against Brain Cancer discusses a specific protein that is being found in nearly 100 percent of high-grade meningiomas, the most common form of brain tumor. According to a September 16, 2013 article published by...

2013-09-24 12:28:16

FDA allows novel approach to study children with inborn errors of energy metabolism MOUNTAIN VIEW, Calif., Sept. 24, 2013 /PRNewswire/ -- Edison Pharmaceuticals announced today initiation of a phase 2 clinical trial titled "Therapeutic Trial of EPI-743 in Patients with Disorders of Energy Utilization or Oxidation-Reduction." The trial is a double-blind, placebo-controlled crossover study in which subjects will receive either EPI-743 treatment or placebo for six months. They will...

2013-09-24 08:30:24

--New Company Is Leveraging Discoveries and Expertise of Cancer Researchers at LSU's Pennington Biomedical Research Center and Feist Weiller Cancer Center-- BATON ROUGE, La., Sept. 24, 2013 /PRNewswire/ -- K94 Discoveries, Inc., (K94) a new biotechnology company applying hormone receptor-targeting technology to develop novel cancer therapies, today announced that it has closed a $300,000 seed financing. The financing was provided by BVM Capital, LLC, through its Themelios Ventures...

2013-09-19 23:00:23

Dr. Monica Swahn, professor in the School of Public Health and associate vice president for research at Georgia State University, has received a two-year, $390,000 grant from the National Institutes of Health (NIH) to study the role of alcohol marketing and early alcohol use among African youth acquiring HIV. Atlanta, Georgia (PRWEB) September 20, 2013 Dr. Monica Swahn, professor in the School of Public Health and associate vice president for research at Georgia State...